Amgen bets on stem cell company Fortuna Fix in $25M round – Endpoints News
Endpoints News |
Amgen bets on stem cell company Fortuna Fix in $25M round
Endpoints News The company says it's reproduced this phenomena in test tubes by starting with regular old multipotent stem cells, which can be taken from any tissue (hair, skin, bone marrow, etc.) and re-engineered into neural stem cells. There's a name for this kind … Amgen makes regenerative medicine play, backing $25M Fortuna … |
